Skip to main content
ANNX logo

ANNX

Annexon, Inc.
$6.43 +0.47 (+7.89%) At close · Jul 7
Market Cap
$1.28B
Shares
199,608,337

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$6.43 Open$5.99 Day$5.83–6.47 52W$1.85–7.18 Avg vol 30d3.9M Short int26.4M · 13.2% float · 9.3d Short vol31% Last earningsMay 7, 2026 DataJul 2020–Jul 2026 Filing10-Q · May 7
Equibles Rating blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 16.9 · calm Equity put/call 0.86
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +31%
above
Price vs 50-day avg +19%
above
RSI (14) 71
overbought
MACD trend Positive
52-week position 86%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +22%
trailing
6-month return +16%
trailing
YTD return +28%
this year
Relative strength +8%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow Distributing
3 of 216 funds reported for Jun 30 · net -2.4K sh shares
Insider flow Accumulating
Net +$3.4M over 90 days · 0% sells
Short interest Rising
13.22% of float · ▲ +2.1% MoM · 9.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
216 holders — near 3-yr high, broad support
Squeeze score 64
elevated · 0–100
Fundamentals
Weak
EPS growth −33%
Y/Y
Free cash flow $-186.5M
Balance sheet $162.1M
net cash
Quant / Vol
risk profile
Very High
Volatility 78%
annualized · 1-yr
Max drawdown −35%
past year
ATR 6.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Up next
Next earnings call
Aug 6, 2026 Est · unconfirmed · in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 7, 2026

Technicals

trend & momentum for long-term holders Buy
1 · 2 · 4
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+31% Bullish
Price vs 50-day avg
+19% Bullish
RSI (14)
71 Bearish
MACD trend
Positive Bullish
52-week position
86% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow Distributing
3 of 216 funds reported for Jun 30 · net -2.4K sh shares
Insider flow Accumulating
Net +$3.4M over 90 days · 0% sells
Short interest Rising
13.22% of float · ▲ +2.1% MoM · 9.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
216 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $2 Now $6 · 86% 52-wk high $7
vs 200-day avg +31% vs 50-day avg +19%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings
Metric Latest Period YoY
ARCHER II trial enrollment 659 as of July 2025

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ANNX
Annexon, Inc.
this stock
$1.28B +28.1% 13.2%
ONC
BeOne Medicines Ltd.
$446.53B +1.7% +22179.2% 908.7 0.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
$132.55B +15.2% +46.2% 31.0 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
$70.90B -12.3% +20.8% 16.5 3.2%
ARGX
Argenx SE
$57.20B +8.8% 2.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
216
% held
77.9%
Reported
3 of 216
Top holder
Redmile Group, LLC
Held Float
View
Held by Funds
Fund positions
171
View
Short & Settlement
Short Interest Rising
Shares short
26.4M
Days to cover
9.3d
Change
+554.2K sh
View
Short Volume
Short vol %
31%
As of
Jul 8, 2026
Short Total
View
Fails to Deliver
FTD shares
126.3K
Value
$687.3K
As of
May 22, 2026
View
Off-Exchange
Off-exchange %
34.7%
Week of
May 4, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$3.4M
Buyers / Sellers
2 / 0
Buyers Sellers
View
Financials
Financials
Net income (FY)
$-206.7M
EPS diluted
$-1.34
View
Filings
SEC Filings
Latest
Investor Event Transcript
Filed
Jun 30, 2026
This year
11
View
Proposed Sales
Value
$23.5K
Shares
4.3K
Filed
Mar 2, 2026
View
Exempt Offerings
Offering
$130.5M
Filed
Jul 22, 2022
View
Earnings & Events
Earnings Calls
Last call
Jun 9, 2026
View

Performance

5D 20D 120D MTD YTD
ANNX +15.4% +21.6% +15.7% +12.6% +28.1%
SPY +0.9% +1.4% +7.6% +0.1% +9.7%
vs SPY +14.5% +20.2% +8.1% +12.5% +18.4%
Key facts CIK 1528115 CUSIP 03589W102 13F (30d) 5 filings 5 filers Visit website Investor relations